Addimmune Overview
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
- Investors
-
4
Addimmune General Information
Description
Developer of cell and gene therapy intended to develop an immune regulatory functional cure for HIV. The company's investigational cell therapy helps make gene modifications to immune cells to make them harder to infect by HIV and next-gen anti-HIV drugs to increase their efficacy or reduce side effects, enabling healthcare practitioners to provide treatments to patients.
Contact Information
Website
www.addimmune.comCorporate Office
- 9713 Key West Avenue
- 5th Floor
- Rockville, MD 20850
- United States
Corporate Office
- 9713 Key West Avenue
- 5th Floor
- Rockville, MD 20850
- United States
Addimmune Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 3. Early Stage VC | 01-Feb-2024 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 30-Jun-2022 | Completed | Clinical Trials - Phase 1 | |||
| 1. Reverse Merger | 09-Aug-2023 | Cancelled | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Addimmune Comparisons
Industry
Financing
Details
Addimmune Competitors (5)
One of Addimmune’s 5 competitors is Sangamo Therapeutics, a Formerly VC-backed company based in Richmond, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| ViiV Healthcare | Corporate Backed or Acquired | London, United Kingdom | ||||
| Aelix | Corporation | Cassola, Italy |
Addimmune Signals
Addimmune Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gaingels | Venture Capital | Minority | ||
| ROC Venture Group | Venture Capital | Minority | ||
| Opus8 | PE/Buyout | Minority | ||
| Ossian Capital | Venture Capital | Minority |
Addimmune FAQs
-
Where is Addimmune headquartered?
Addimmune is headquartered in Rockville, MD.
-
What is the size of Addimmune?
Addimmune has 6 total employees.
-
What industry is Addimmune in?
Addimmune’s primary industry is Biotechnology.
-
Is Addimmune a private or public company?
Addimmune is a Private company.
-
What is Addimmune’s current revenue?
The current revenue for Addimmune is .
-
How much funding has Addimmune raised over time?
Addimmune has raised $50M.
-
Who are Addimmune’s investors?
Gaingels, ROC Venture Group, Opus8, and Ossian Capital have invested in Addimmune.
-
Who are Addimmune’s competitors?
Sangamo Therapeutics, Immunocore Holdings, Gilead, ViiV Healthcare, and Aelix are competitors of Addimmune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process